title: Dyskinesias in levodopa-carbidopa intestinal gel infusion era: New challenges, new features.
authors.affiliation: Unidad de Trastornos del Movimiento, Servicio de Neurología, Hospital Clínico San Carlos, Madrid, Spain.
authors.forename: María-José
authors.initials: MJ
authors.lastname: Catalán
authors.affiliation: Unidad de Trastornos del Movimiento, Servicio de Neurología, Hospital Clínico San Carlos, Madrid, Spain.
authors.forename: Paloma Montero
authors.initials: PM
authors.lastname: Escribano
authors.affiliation: Unidad de Trastornos del Movimiento, Servicio de Neurología, Hospital Clínico San Carlos, Madrid, Spain.|HM CINAC, Hospital Universitario HM Puerta del Sur, Mostoles. Universidad San Pablo CEU, Madrid, Spain.
authors.forename: Fernando
authors.initials: F
authors.lastname: Alonso-Frech
mesh_terms: D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000494:pharmacology*; D002230:Carbidopa / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000494:pharmacology*; D004338:Drug Combinations; D004409:Dyskinesia, Drug-Induced / Q000503:physiopathology*; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*
chemical_list: D000978:Antiparkinson Agents; D004338:Drug Combinations; C009265:carbidopa, levodopa drug combination; D007980:Levodopa; D002230:Carbidopa
keywords: Parkinson's disease; dyskinesia; levodopa carbidopa intestinal gel